Omega-3 Supplementation May Prevent Psychosis Development
the MPR take:
In previous studies, omega-3 fatty acids have been shown to help cut smoking cravings and reduce behavior problems in children. Now new research presented at the International Early Psychosis Conference demonstrates that patients who are at an increased risk for developing psychosis may also benefit from omega-3 supplementation. Back in 2010, Dr. Paul Amminger and his colleagues had published data which showed that a 12-week intervention with omega-3 supplementation reduced the risk of psychosis progression in high-risk young patients for over one year. In a recent follow-up trial, the researchers found that this brief intervention had a lasting effect, preventing psychosis onset for seven years. Patients in the omega-3 group also showed improvement in overall symptoms and psychosocial functioning compared to patients in the placebo group. Men and women had similar results but the researchers posit that patients who are deficient in fatty acids and have more negative symptoms will likely benefit most from omega-3 supplementation. The researchers conclude that omega-3 supplementation may be a safe, long-term prevention strategy for patients at high risk for psychosis, however more research needs to be done before this recommendation can be made. Efficacy trials are currently being conducted with results expected in March 2015.
READ FULL ARTICLE From Forbes